OpenAlex
PricingAboutJobs
Log inGet started
Work

A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice

HTML

Year: 2009
Type: article
Source: Vaccine
DOI: 10.1016/j.vaccine.2009.03.036
Authors: Shen-An Hwang, Katarzyna Wilk, Marian L. Kruzel, Jeffrey K. Actor
Language: English

Topic: Tuberculosis Research and Epidemiology
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: recombinant human lactoferrin, BCG vaccine, Mycobacterium tuberculosis, glycoengineering, Pichia pastoris, vaccine adjuvants, lung pathology, cell-mediated immunity, tuberculosis protection
SDG: Good health and well-being

Open Access status: green

Funders: National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Awards: Lactoferrin for Immunomodulation of Systemic Inflammatory Response Syndrome, Lactoferrin as an Adjuvant for Cellular Immunity
OpenAlex ID: W2050577458
FWCI: 2.77
Cites: 62
Cited by: 35
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security